2013
DOI: 10.2174/2210289201304010294
|View full text |Cite
|
Sign up to set email alerts
|

New Flavonoids Derivatives from with Antioxidant, Antimicrobial and Cyotoxic Activities

Abstract: Detailed investigation on leaves and bark of Artocarpus elasticus has led to the isolation of eight flavonoids derivatives including four new compounds, artoelastil (1), artoelastidi (2), artoelastiq (3), and artoelastidi (4) together with four known compound identified as cycloartocarpesin (5), artonin E (6), cycloartobiloxanthone (7) and artobiloxanthone (8). The structural elucidations of the pure compound were carried out using spectroscopic methods such as UV, IR, NMR, MS and also by comparison with publi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…It is exceptionally rich in phenolic secondary metabolites such as flavonoids, chalcones, xanthones and arylbenzofurans [10,11]. Some of these constituents have been reported to possess anti-inflammatory, anti-proliferative [12,13], antimicrobial [12] anti-tubercular [10] and antioxidant properties [14]. However, small molecules from this Artocarpus have not been investigated for their binding affinities to the human estrogen receptor and their drug-likeness has not been reported.…”
Section: Introductionmentioning
confidence: 99%
“…It is exceptionally rich in phenolic secondary metabolites such as flavonoids, chalcones, xanthones and arylbenzofurans [10,11]. Some of these constituents have been reported to possess anti-inflammatory, anti-proliferative [12,13], antimicrobial [12] anti-tubercular [10] and antioxidant properties [14]. However, small molecules from this Artocarpus have not been investigated for their binding affinities to the human estrogen receptor and their drug-likeness has not been reported.…”
Section: Introductionmentioning
confidence: 99%